Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Sunday, February 1, 2026.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Weak Downtrend (-65) - XERS is showing signs of a strengthening downtrend. Monitor XERS as it may be building momentum to the downside.
Is it time to buy, sell, or avoid XERS?
MarketClub looks at technical strength and momentum to determine if the timing is right for XERS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for XERS
The long-term trend has been DOWN since Dec 2nd, 2025 at 6.7100
The intermediate-term trend has been UP since Jan 8th, 2026 at 8.2199
The short-term trend has been DOWN since Jan 26th, 2026 at 7.4300
Smart Scan Analysis for XERS
Based on our trend formula, XERS is rated as a -65 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 7.3000 | 7.4499 | 7.2200 | 7.3650 | +0.1250 |
| Prev. Close | Volume | Bid | Ask | Time |
| 7.3600 | 1111126 | 2026-01-30 15:59:58 |
| Year High | 27.9826 | Year High Date | 2018-09-12 |
| Year Low | 15.75 | Year Low Date | 2018-06-21 |
| 52wk High | 10.08 | 52wk High Date | 2025-11-05 |
| 52wk Low | 3.445 | 52wk Low Date | 2025-02-11 |
| Average Volume | 2,344,299 | Shares Outstanding | 165,924 |
| Market Cap | 275M | Assets | 370,191,000M |
| Liabilities | 371,052,000M | Volatility | 56.41 |
